MyFinsight
Home
Blog
About
Semnur Pharmaceuticals, Inc. (DNQAF)
Semnur Pharmaceuticals, Inc. (DNQAF)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Stock-based compensation
Other assets
Proceeds from related party loan...
Others
Negative Cash Flow Breakdown
Net loss
Payments of deferred offering co...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net loss
-153,678,275
-579,725
Income from trust
-
97,051
Stock-based compensation
140,403,000
-
Prepaid expenses
-4,018
14,018
Accrued interest expense - others
-
19,638
Other assets
-9,851,000
-
Accrued interest expense -related party
-
35,682
Accounts payable
521,000
-
Accounts payable and accrued expenses
-
451,962
Accrued expenses
1,231,000
-
Net cash used in operating activities
-2,078,488
-183,512
Cash withdrawn from trust account in connection with redemption
-
8,617,553
Net cash generated by investing activities
-
8,617,553
Business combination
26,000
-
Proceeds from related party loans
9,744,230
166,770
Redemption of ordinary shares
-
8,617,553
Payments of deferred offering costs
7,602,000
-
Net cash (used in) provided by financing activities
10,785,783
-8,450,783
Net change in cash and cash equivalents
89,742
-16,742
Cash and cash equivalents at beginning of period
12,000
-
Cash and cash equivalents at end of period
85,000
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from related
party loans
$9,744,230
something is missing
$8,617,553
Business combination
$26,000
Net cash (used in)
provided by financing...
$10,785,783
Canceled cashflow
$7,602,000
Net change in cash
and cash...
$89,742
Canceled cashflow
$10,696,041
Payments of deferred
offering costs
$7,602,000
Stock-based compensation
$140,403,000
Other assets
-$9,851,000
Accrued expenses
$1,231,000
Accounts payable
$521,000
Prepaid expenses
-$4,018
something is missing
-$8,617,553
Net cash used in
operating activities
-$2,078,488
Canceled cashflow
$152,010,018
Net loss
-$153,678,275
something is missing
-$410,231
Buy us a coffee